In addition to inhibiting the MBNL1-CUG interaction in vitro and dissolving nuclear foci in DM1 cells, treatment with this substance ameliorated DM1 phenotypes in Drosophila including the adult external eye degeneration and larval crawling defect (Table 1) [68]. This evidence concerns the gene MBNL1 and myotonic dystrophy type 1.